MAPS Act

The MAPS Act requires the U.S. Department of Health and Human Services to maintain an Essential Medicines List focusing on drugs critical for public health emergencies, high-risk shortages, and chronic conditions. It mandates annual risk assessments of supply chains for these medicines, identifying vulnerabilities like single-source suppliers or foreign dependencies, and requires mapping of manufacturing and distribution pathways. The law directs HHS to publish the list and submit annual reports to Congress on supply chain risks, including cybersecurity threats and gaps in domestic manufacturing. This directly affects national health security planning and federal efforts to prevent drug shortages impacting patients and emergency response systems.